Braskem S.A.
NYSE:BAKChemicals
-$0.40 today
- Market cap
- $343.37M
- Beta
- 0.67
- P/E (TTM)
- -0.7
- EPS (TTM)
- -$11.45
Volume 3.32M
Average 2.97M
BAK Total Current Liabilities
All obligations due within one year.
Braskem S.A.NYSE: BAK
Total Current Liabilities · Q1 FY2026 · quarter ended Mar 2026
Total current liabilities rises 40.8% from a year ago
Total current liabilities stood at R$36.46B at the end of Q1 FY2026, up 40.8% from a year earlier and down 9.3% from the prior quarter. Over 3 fiscal years it compounded at +18.5% a year.
Context
- Total current liabilities amounted to 48.6% of total assets at the end of Q1 FY2026, up 21.5 pp from a year earlier.
- Total current liabilities increased in 3 of the last 3 fiscal years.
- FY2025 was the highest annual figure in the 4 fiscal years shown.
What to watch
Whether total current liabilities keeps rising in the next quarterly balance sheet after a +40.8% change from a year earlier.
Sources:Balance SheetText generated from reported figures; not investment advice.
Total Current Liabilities history
BRL · from the balance sheet
- Latest · FY2025
- 40.2B BRL
- Year-over-year change
- +42.2%
- 4-year CAGR
- +12.4%
| Period | Period end | Total Current Liabilities | YoY change |
|---|---|---|---|
| FY2025 | 2025-12-31 | 40.2B | +42.2% |
| FY2024 | 2024-12-31 | 28.27B | +15.4% |
| FY2023 | 2023-12-31 | 24.49B | +1.3% |
| FY2022 | 2022-12-31 | 24.19B | -4.0% |
| FY2021 | 2021-12-31 | 25.19B | — |
Total Current Liabilities vs competitors
How BAK compares with its peers on the latest reported figures
- Peers report in different currencies, so total current liabilities is compared through growth and share of total assets rather than absolute size.
- Its year-over-year change of +40.8% is the 5th highest of 11, against a peer median of +12.4%.
- Total current liabilities amounts to 48.6% of total assets for BAK, versus a peer median of 11.1%.
| Company | Period | Latest balance | YoY | 3-year CAGR | % of assets |
|---|---|---|---|---|---|
| Mar 2026 | R$36.46B BRL | +40.8% | +18.5% | 48.6% | |
| Mar 2026 | $720.45M USD | -2.6% | -0.2% | 30.9% | |
| Mar 2026 | $385.21M USD | -4.8% | +0.6% | 23.1% | |
| Mar 2026 | $127.9M USD | +22.9% | -2.3% | 10.3% | |
| Mar 2026 | $98.57M USD | -0.4% | -8.4% | 9.7% | |
| Mar 2026 | $96.67M USD | +113.6% | -8.8% | 9.9% | |
| Mar 2026 | CA$76.55M CAD | +1.8% | +267.7% | 64.1% | |
| Mar 2026 | $70.37M USD | +759.7% | +156.5% | 12.0% | |
| Apr 2026 | $65.32M USD | +53.4% | +11.3% | 8.1% | |
| Mar 2026 | $40.79M USD | -75.3% | -8.5% | 3.3% | |
CNLCollective Mining Ltd. | Mar 2026 | $24.34M USD | +550.7% | +40.0% | 13.0% |
| Peer median (excluding BAK) | — | +12.4% | +0.2% | 11.1% | |
Competitors are the stored peer set for BAK. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Balance Sheet
Metric | FY2021 Dec 2021 | FY2022 Dec 2022 | FY2023 Dec 2023 | FY2024 Dec 2024 | FY2025 Dec 2025 |
|---|---|---|---|---|---|
| Cash & Equivalents | 8.68B | 12.47B | 14.19B | 14.99B | 10.5B |
| Short-term Investments | 3.49B | 2.3B | 4.96B | 1.79B | 1.34B |
| Net Receivables | 10.75B | 5.51B | 5.63B | 6.5B | 8.19B |
| Inventory | 16.27B | 13.91B | 12.38B | 13.47B | 10.42B |
| Other Current Assets | 33.82M | 158M | 137M | 73M | 0 |
| Total Current Assets | 39.29B | 34.46B | 37.44B | 37.04B | 30.43B |
| Property, Plant & Equipment (Net) | 40.01B | 41.72B | 42.23B | 44.14B | 41.44B |
| Goodwill | 2.06B | 2.09B | 2.17B | 2.18B | 1.94B |
| Intangible Assets | 818.43M | 935M | 935M | 1.21B | 1.12B |
| Long-term Investments | 75.77M | 149M | 165M | 438M | 994.5M |
| Tax Assets | 8.26B | 6.36B | 6.44B | 13.88B | 1.56B |
| Other Non-current Assets | 2.06B | 2.35B | 2.36B | 2.7B | 4.35B |
| Total Non-current Assets | 53.27B | 53.59B | 54.3B | 64.54B | 51.41B |
| Total Assets | 92.56B | 88.05B | 91.74B | 101.58B | 81.84B |
| Account Payables | 12.05B | 12.25B | 13.22B | 16.88B | 13.17B |
| Short-term Debt | 1.49B | 2.25B | 2.77B | 3.14B | 21.66B |
| Tax Payables | 2.68B | 872M | 398M | 868M | 0 |
| Deferred Revenue | 204.67M | 0 | 0 | 0 | 0 |
| Other Current Liabilities | 5.25B | 5.37B | 4.1B | 3.27B | 4.55B |
| Total Current Liabilities | 25.19B | 24.19B | 24.49B | 28.27B | 40.2B |
| Long-term Debt | 49.56B | 47.33B | 53.21B | 66.28B | 46.37B |
| Deferred Tax Liabilities | 2.12B | 1.89B | 2.35B | 1.69B | 1.47B |
| Deferred Revenue (Non-current) | 257.86M | 0 | 0 | 0 | 0 |
| Other Non-current Liabilities | 6.74B | 5.33B | 5.45B | 6.3B | 7.05B |
| Total Non-current Liabilities | 61.17B | 57.76B | 63.97B | 77.58B | 58.13B |
| Total Liabilities | 86.36B | 81.94B | 88.46B | 105.85B | 98.33B |
| Common Stock | 8.04B | 8.04B | 8.04B | 8.04B | 8.04B |
| Retained Earnings | 536.76M | 253.27M | (2.74B) | (14.03B) | (24.38B) |
| Accumulated OCI | 317.25M | (244M) | (852M) | 1.7B | 199.9M |
| Other Stockholders Equity | 31.93M | 39M | 37M | 0 | 0 |
| Minority Interest | (1.66B) | (1.21B) | (713M) | 504M | (354.82M) |
| Total Equity | 6.2B | 6.11B | 3.28B | (4.28B) | (16.49B) |
| Total Debt | 54.21B | 53.83B | 59.91B | 73.72B | 71.28B |
| Net Debt | 45.53B | 41.36B | 45.72B | 58.74B | 60.78B |
Braskem S.A.
NYSE:BAK
Intrinsic Alpha fair value
Locked
Current Price
$0.86
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.